BOSTON, Sept. 17, 2020 /PRNewswire/ — In today’s digital age, focus on digital health and the quantified self have led to the rapid rise of heart rate monitoring technologies through wearables such as fitness trackers and smartwatches. Such devices have already proven their ability in detecting hidden heart conditions such as tachycardia […]
Author: Ken Dropiewski
Shape Memory Medical Announces First Patient Enrollment in AAA-SHAPE Study
SANTA CLARA, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced the initiation of AAA-SHAPE, the Company’s prospective safety study of the IMPEDE-FX Embolization Plug devices when used for abdominal aortic aneurysm (AAA) sac filling during elective endovascular aneurysm repair (EVAR). The study’s first […]
Medtronic TYRX™ Absorbable Antibacterial Envelope Is Cost Effective for Patients at Increased Risk of Infections
Economic Analysis of the WRAP-IT Patient Population in Circulation: Arrhythmia and Electrophysiology Long-Term Results from WRAP-IT, Data on Impact of Infections Also Published DUBLIN, Sept. 16, 2020 /PRNewswire/ — Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced new data from the landmark WRAP-IT study, showing the TYRX™ Absorbable Antibacterial Envelope […]
Novartis US Foundation commits $25M to improve health equity by reducing health disparities in the US
Building on $10M+ commitments to date, US Foundation is providing up to an additional $15M due to emergence of COVID-19 pandemic and elevated focus on social injustice Commitment to include partnerships and support to address the underrepresentation of minorities, including African American/Black and Hispanic communities, in clinical trials Reinforces US […]
JanOne Announces Strategic Plan to Divest its Legacy Businesses
Update on plans for sale of recycling business. Divesting will allow for focus on core life science assets LAS VEGAS, Sept. 16, 2020 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, provided an update today regarding its initiatives […]
DiNAQOR AG Appoints Eduard Ayuso as Chief Technology Officer
Company Also Expands Advisory and Leadership Teams with New Member of Scientific Advisory Board, Chairman of DiNAQOR UK, and General Counsel PFÄFFIKON, Switzerland, Sept. 16, 2020 /PRNewswire/ — DiNAQOR AG, a gene therapy platform company, today announced that Eduard Ayuso, D.V.M., Ph.D. has been appointed as Chief Technology Officer. The Company also announced the addition of Mauro Giacca, […]
CoreMap Completes $10.5 Million Series A Financing
Round led by Qure Ventures Will Accelerate Development of CoreMap’s Technology to Enable Curative, Patient-Specific Treatment of Atrial Fibrillation BURLINGTON, Vt., Sept. 16, 2020 (GLOBE NEWSWIRE) — CoreMap announced today it has completed a $10.5 million Series A financing led by Qure Ventures. The round included both existing investors such […]
VitalConnect Announces Initiation of TELESTAR-TAVR Clinical Study
Study will evaluate the impact of remote patient monitoring on clinical outcomes, readmission rates, and patient satisfaction following a transcatheter aortic valve replacement procedure SAN JOSE, Calif.–(BUSINESS WIRE)–VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, announced today that it has begun the TELESTAR-TAVR clinical study (Deployment of Telemedicine […]
Moderna and Chiesi Group Establish Collaboration to Discover and Develop mRNA Therapeutics for Pulmonary Arterial Hypertension (PAH)
CAMBRIDGE, Mass. & PARMA, Italy–(BUSINESS WIRE)–Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients and Chiesi Farmaceutici S.p.A., an international research-focused healthcare group (Chiesi Group), today announced a collaboration aimed at the discovery and development […]
Corventive Health to Deliver American College of Cardiology’s Evidence-Based Content in its Innovative Cardiac Care Solutions
Corventive Now Delivers Evidence-Based Content to Enhance Patient Care. NEWTOWN, Pa., Sept. 15, 2020 /PRNewswire/ — Corventive Health, a provider of cloud-based and AI technology solutions, announced its plan to integrate American College of Cardiology (“ACC”) evidence-based content into its innovative cardiac solutions. Incorporating ACC clinical content enables Corventive to deliver insights designed […]



